10x Genomics Inc - Class A (TXG) Company Profile & Statistics

10x Genomics Inc - Class A
TXG
(Nasdaq - US)
Open
13.27
-0.07 (-0.53%)
in:usd•As of: Nov 18, 2024 13:34 UTC -5
Open
13.34
High
13.44
Low
13.13

About 10x Genomics Inc - Class A

CEO

Serge Saxonov

Headquarters

6230 stoneridge mall road

pleasanton, ca 94588, united states

Auditor

Ernst & Young LLP

Employees

451

Share Holders

Website

www.10xgenomics.com

Industry

biotechnology

Sector

health technology

Company Overview

10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California.

10x Genomics Inc - Class A Statistics

Valuation Measures

Market Capitalization ²	1.61B
Enterprise Value	1.22B
Enterprise Value/EBITDA (ttm)	-7.85
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	2.23
Price to Sales (ttm)	2.56
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	66.76%
Operating Margin (ttm)	-28.93%
Profit Margin (ttm)	-29.36%
Return on Equity (ttm)	-25.07%
Return on Invested Capital (ttm)	-25.13%
Return on Assets (ttm)	-19.41%

Income Statement

Revenue (ttm)	629.74M
Revenue Per Share (ttm)	5.20
Gross Profit (ttm)	419.31M
EBITDA (ttm)³	-155.06M
Net Income Avi to Common (ttm)	-182.55M
Diluted EPS (ttm)	-1.53

Share Statistics

Beta (5Y Monthly)	1.87
52-Week Change	-69.44%
S&P500 52-Week Change	29.71%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	121.05M
Dividend Yield	0.00%
Float ⁴	108.91M
% Held by Insiders	10.03%
% Held by Institutions	84.68%

Balance Sheet

Total Cash (mrq)	398.16M
Total Cash Per Share (mrq)	3.29
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	4.90%
Quick Ratio (mrq)	4.12%
Book Value Per Share (mrq)	5.97

Cash Flow

Operating Cash Flow Per Share (ytd)	0.11
Free Cash Flow (ytd)	3.73M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

10x Genomics Inc - Class A

Trade With A Regulated Broker